Fluofarma

Fluofarma is a leading company in High Content Screening (HCS) providing services to improve the drug discovery potential of its clients.

Fluofarma's know how

Fluofarma combines unparalleled know how in cell biology, assay development, cutting edge High Content Screening technologies and exclusive data mining capabilities to support drug discovery programs.

Application domains

Fluofarma has built a deep knowledge in numerous fields such as oncology, neurobiology, drug toxicity, cardiology and cosmetics. However Fluofarma’s technologies can be applied to all fields of drug discovery.

Fluofarma's offer

The Fluofarma divisions provide the most complete High Content Screening service offer on the market.

Bioengineering

Development of new cell-based assay
Customization of cell-based assay
Miniaturization of cell-based assay
Mechanism of Action studies

Bioscreening

Portfolio of over 600 cell-based assays
By cellular fonction
By domains

Biocomputing

Custom development of software applications
Custom design of algorithms
Data analysis

Over 40 major pharmaceutical and biotechnology companies worldwide have already used Fluofarma services to evaluate the effects of their compounds.

Breaking news

  • High Content Analysis 2012

    Fluofarma will be attending the High Content Analysis 2012 in San Francisco, from January 9th to 12th. We look forward to seeing you at our booth (n° 34) and your are welcome the 11th at the « Luncheon Technology Showcase: High-Content Data Analysis » where Fluofarma will present CytoSurfe®r. An innovative and intuitive software application for High content image analysis.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "The American Journal of Pathology".

    Read more [+]